HIGHLIGHTS
- who: Alessandro Busca and colleagues from the Ottawa Research Institute (OHRI), Canada Stem Cell Transplant Center, AOU Citta` della Salute della Scienza, Turin, Italy, University of Cologne have published the article: Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry, in the Journal: (JOURNAL)
SUMMARY
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was recognized in late 2019 and developed into a pandemic with lifethreatening disease documented in high-risk groups. Allogeneic hematopoietic stem_cell transplantation (HSCT) has been increasingly adopted as a curative treatment option for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.